$57.39
Legend Biotech Corp is a biotechnology business based in the US. Legend Biotech Corp shares (LEGN) are listed on the NASDAQ and all prices are listed in US Dollars. Legend Biotech Corp employs 2,200 staff and has a trailing 12-month revenue of around $456 million.
Our top picks for where to buy Legend Biotech Corp stock
How to buy Legend Biotech Corp stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – LEGN. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Legend Biotech Corp stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Legend Biotech Corp stock price (NASDAQ: LEGN)
Use our graph to track the performance of LEGN stocks over time.Legend Biotech Corp shares at a glance
Latest market close | $57.33 |
---|---|
52-week range | $38.60 - $70.78 |
50-day moving average | $53.46 |
200-day moving average | $54.73 |
Wall St. target price | $82.99 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-1.54 |
Is it a good time to buy Legend Biotech Corp stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Legend Biotech Corp price performance over time
Historical closes compared with the close of $57.33 from 2024-09-03
1 week (2024-08-29) | 1.09% |
---|---|
1 month (2024-08-05) | 7.40% |
3 months (2024-06-05) | 31.37% |
6 months (2024-03-05) | -9.94% |
1 year (2023-09-05) | -16.61% |
---|---|
2 years (2022-09-02) | 24.28% |
3 years (2021-09-03) | 47.23% |
5 years (2019-09-01) | N/A |
Legend Biotech Corp financials
Revenue TTM | $456 million |
---|---|
Gross profit TTM | $-284,006,000 |
Return on assets TTM | -12.52% |
Return on equity TTM | -22.21% |
Profit margin | -62.5% |
Book value | $6.33 |
Market Capitalization | $10.5 billion |
TTM: trailing 12 months
Legend Biotech Corp share dividends
We're not expecting Legend Biotech Corp to pay a dividend over the next 12 months.
Legend Biotech Corp share price volatility
Over the last 12 months, Legend Biotech Corp's shares have ranged in value from as little as $38.6 up to $70.78. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Legend Biotech Corp's is 0.108. This would suggest that Legend Biotech Corp's shares are less volatile than average (for this exchange).
Legend Biotech Corp overview
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery, development, manufacturing, and commercialization of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multiple myeloma (MM). The company also has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including Non-Hodgkins Lymphoma, acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, hepatocellular carcinoma, small cell lung cancer, and non-small cell lung cancer. It has collaboration and license agreement with Janssen Biotech, Inc. for the development and commercialization of ciltacabtagene autoleucel. The company was founded in 2014 and is based in Somerset, New Jersey. Legend Biotech Corporation operates as a subsidiary of Genscript Biotech Corporation.
Frequently asked questions
What percentage of Legend Biotech Corp is owned by insiders or institutions?Currently 1.311% of Legend Biotech Corp shares are held by insiders and 51.728% by institutions. How many people work for Legend Biotech Corp?
Latest data suggests 2,200 work at Legend Biotech Corp. When does the fiscal year end for Legend Biotech Corp?
Legend Biotech Corp's fiscal year ends in December. Where is Legend Biotech Corp based?
Legend Biotech Corp's address is: 2101 Cottontail Lane, Somerset, NJ, United States, 08873 What is Legend Biotech Corp's ISIN number?
Legend Biotech Corp's international securities identification number is: US52490G1022
More guides on Finder
-
Best options trading platforms of 2024
SoFi, Robinhood, Tastytrade, Webull, Interactive Brokers, E*TRADE, eToro and others top our list for the best options trading platforms.
-
What is a covered call?
A covered call is an options trading strategy that allows you to generate income from stocks you already own.
-
6 stocks like Nvidia you need to consider
Advanced Micro Devices (AMD), Intel Corporation (INTC) and Qualcomm Inc (QCOM) are top stocks like Nvidia. See our full list here.
-
Frec review 2024: Low-cost direct indexing and individual stock trading
A deep dive into the highlights and limitations of Frec.
-
Public vs. Robinhood
Compare pros, cons, research tools and reviews for these two trading platforms.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
Streitwise review
An online REIT with low fees, consistent dividends and a stable portfolio, but a brief track record.
-
Interactive Brokers review 2024: Tailored trading and investing
Interactive Brokers has advanced charting tools but a high net requirement to qualify.
-
Top 15 tech stocks to invest in for 2024
Discover the top tech stocks poised to lead innovation and offer substantial growth opportunities.
-
Wealthfront review: Low-cost automated and DIY investing
Learn about Wealthfront’s automated investing tools and services to see if it’s the right platform for you.
Ask a question